Tyagarajan Seshu

Candel Therapeutics, Inc. · Chief Technology Officer

Tyagarajan Seshu is listed in filings as Chief Technology Officer at Candel Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 28, 2026, including sale activity. Recent filings connect the profile to Candel Therapeutics, Inc. (CADL). The current snapshot covers public activity from Jul 15, 2024 to Jan 28, 2026. Reported amounts are shown as $925.5K to $275.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Candel Therapeutics, Inc.CADL$103k14.3k sharesSellJan 15, 2025$7.23$8.09
Candel Therapeutics, Inc.CADL$120k14.5k sharesSellJan 8, 2025$8.22$8.09
Candel Therapeutics, Inc.CADL$93k20.4k sharesSellNov 29, 2024$4.56$8.09
Candel Therapeutics, Inc.CADL$96k14.9k sharesSellJul 17, 2024$6.47$8.09
Candel Therapeutics, Inc.CADL$80k13.3k sharesSellJul 11, 2024$5.97$8.09